Direct2Attorney is a legal marketing & referral service, not a law firm and not a substitute for legal advice.
THE CLAIM DESK
Ongoing coverage of GLP-1 drug litigation involving Ozempic, Wegovy, Mounjaro, and Zepbound. Topics include gastroparesis and bowel obstruction claims, NAION vision loss cases, MDL developments, bellwether scheduling, and eligibility criteria for new claims.
Ozempic LawsuitOct 5, 2026 · 8 min readOzempic Lawsuit Eligibility: 6 Essential Factors to Know in 2026Ozempic lawsuit eligibility explained: qualifying GI and vision injuries, key medical records, deadlines and where MDL 3094 stands as of October 2026.Read the guide →
Ozempic LawsuitSep 25, 2026 · 8 min readOzempic Vision Loss Lawsuit: NAION MDL 3163 Explained (2026)Ozempic vision loss lawsuit guide: what NAION is, where GLP-1 MDL 3163 stands as of October 2026, who may qualify and which records to…Read the guide →
Ozempic LawsuitSep 11, 2026 · 12 min readOzempic Gastroparesis Lawsuit: The Crucial Test Rule in 2026Ozempic gastroparesis lawsuit: why the gastric emptying test matters, what records help and who may qualify for a claim. Get a free, confidential review.Read the guide →A free, confidential review tells you whether a participating law firm may look at your claim. About 2 minutes, no cost, no obligation.
